Top Markets
Coin of the day
Regen BioPharma, Inc. Regen BioPharma, Inc.

Regen BioPharma, Inc.

RGBP
Rank in Stocks #42223
Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine... Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States. It actively researches and identifies small molecule compounds designed to modulate the NR2F6 gene. This modulation is strategically aimed at activating immune cells for oncology treatments and suppressing them for autoimmune conditions. Its therapeutic pipeline and product development are currently in their initial phases. Established in 2012, the firm operates from its headquarters in La Mesa, California.
Share Price
$0.0001
Market Cap
$3.16K
Change (1 day)
0.00%
Change (1 year)
-99.75%
Country
US
Trade Regen BioPharma, Inc. (RGBP)

Category

EPS for Regen BioPharma, Inc. (RGBP)
EPS as of 2026 TTM: 0
According to Regen BioPharma, Inc. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Regen BioPharma, Inc. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
$17.32 -
US
$27.74 -
NL
- -
CH
$13.70 -
BE
- -
KR